Table 2.
Model | Pathological changes | Alteration |
STZ-induced diabetes | Leukocytosis | Decrease (75%) |
STZ-induced diabetes | Vascular leakage | Decrease (60%) |
STZ-induced diabetes | Acellular capillaries | Decrease (45%) |
STZ-induced diabetes | Vascular leakage | Decrease (60.0%) |
Oxygen-induced retinopathy | Pre-retinal neovascularization | Decrease (34%) |
Oxygen-induced retinopathy | Neovascularization area | Decrease (40%) |
Oxygen-induced retinopathy | Vaso-obliteration area | Decrease (30%) |
STZ: Streptozotocin.